Percheron Therapeutics (AU:PER) has released an update.
Percheron Therapeutics is launching a share purchase plan (SPP) for its shareholders in Australia and New Zealand, offering shares at a 14% discount. This initiative aims to raise up to A$2 million, following a recent A$13 million institutional placement. The SPP provides an opportunity for investors to buy shares at the same price as the institutional investors, with applications capped at A$30,000 per shareholder.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.